Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer — Manel Esteller (1997) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer
Shared by
Manel Esteller
University of Barcelona
The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer
Article
1997
en
Authors
+2 more
Manel Esteller
University of Barcelona
ÁG
Ángel García
JM
J.M. Martínez-Palones
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2004
CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer
Manuel Irimia
,
Mario F. Fraga
,
Montse Sánchez‐Céspedes
,
Manel Esteller
Article
2002
Diet and K-ras mutations in colorectal cancer.
Vı́ctor Moreno
,
Elisabet Guinó
,
F. Xavier Bosch
,
aaa bbb
,
Gabriel Capellà
,
M. Navarro
,
J. Martı́
,
M. Cambray
,
B. Lloberas
Article
1995
High rate of <i>MDR</i>‐1 and heterogeneous pattern of <i>MRP</i> expression without gene amplification in endometrial cancer
Manel Esteller
,
J.M. Martínez-Palones
,
Ángel García
,
Jordi Xercavins
,
Jaume Reventós
Article
2002
Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma
Christian A. Koch
,
Steve Huang
,
Zhengping Zhuang
,
Catherine A. Stolle
,
Norio Azumi
,
George Chrousos
,
Alexander O. Vortmeyer
,
Karel Pacák
Article
1996
Trp64Arg mutation in β3-adrenoceptor gene of doubtful significance for obesity and insulin resistance
Pascale Mauriège
,
Claude Bouchard
The Lancet
Discussion(0)
No comments yet. Be the first to comment.